217 related articles for article (PubMed ID: 10349956)
1. Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization.
Soto NE; Vaghjimal A; Stahl-Avicolli A; Protic JR; Lutwick LI; Chapnick EK
Infect Control Hosp Epidemiol; 1999 May; 20(5):351-3. PubMed ID: 10349956
[TBL] [Abstract][Full Text] [Related]
2. Preventing postoperative Staphylococcus infections: an update.
Grady M; Cullen JJ
Surg Technol Int; 2003; 11():57-60. PubMed ID: 12931284
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of nasal mupirocin to prevent Staphylococcus aureus burn wound colonization in routine clinical practice.
Jaspers ME; Breederveld RS; Tuinebreijer WE; Diederen BM
Burns; 2014 Dec; 40(8):1570-4. PubMed ID: 24685351
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocin.
Kooistra-Smid AM; van Zanten E; Ott A; van Dijk SR; Beerthuizen GI; Vogels WH; van Belkum A; Verbrugh HA
Burns; 2008 Sep; 34(6):835-9. PubMed ID: 18242873
[TBL] [Abstract][Full Text] [Related]
5. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
[TBL] [Abstract][Full Text] [Related]
6. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
[TBL] [Abstract][Full Text] [Related]
7. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
[TBL] [Abstract][Full Text] [Related]
8. [Mupirocin: prophylaxis of hospital-acquired infections due to Staphylococcus aureus and sanitation of hospital environment].
Mitrokhin SD
Antibiot Khimioter; 2003; 48(9):13-9. PubMed ID: 15002175
[TBL] [Abstract][Full Text] [Related]
9. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N
Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
Laupland KB; Conly JM
Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
[TBL] [Abstract][Full Text] [Related]
12. Pre-cesarean Staphylococcus aureus nasal screening and decolonization: a prospective randomized controlled trial.
Shrem G; Egozi T; Naeh A; Hallak M; Walfisch A
J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3906-11. PubMed ID: 26857727
[TBL] [Abstract][Full Text] [Related]
13. Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocin.
Boelaert JR; Van Landuyt HW; Gordts BZ; De Baere YA; Messer SA; Herwaldt LA
Infect Control Hosp Epidemiol; 1996 Dec; 17(12):809-11. PubMed ID: 8985768
[TBL] [Abstract][Full Text] [Related]
14. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
15. A neonatal specialist with recurrent methicillin-resistant Staphylococcus aureus (MRSA) carriage implicated in the transmission of MRSA to newborns.
Méan M; Mallaret MR; Andrini P; Recule C; Debillon T; Pavese P; Croizé J
Infect Control Hosp Epidemiol; 2007 May; 28(5):625-8. PubMed ID: 17464930
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
17. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies.
Trautmann M; Stecher J; Hemmer W; Luz K; Panknin HT
Chemotherapy; 2008; 54(1):9-16. PubMed ID: 18063862
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.
Safdar N; Marx J; Meyer NA; Maki DG
Am J Infect Control; 2006 Oct; 34(8):476-83. PubMed ID: 17015152
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology and control of nosocomial methicillin-resistant Staphylococcus aureus infection in a teaching hospital.
Wang JT; Lin SF; Chiu HL; Wang LC; Tai HM; Jiang CF; Chang SC; Chu SH
J Formos Med Assoc; 2004 Jan; 103(1):32-6. PubMed ID: 15026855
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
Dupeyron C; Campillo B; Richardet JP; Soussy CJ
J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
